Drug Type Small molecule drug |
Synonyms- |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors), 50S subunit inhibitors(50S ribosomal subunit inhibitors), CYP51A1 inhibitors(Cytochrome P450 51 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC66H76Cl3N9O24 |
InChIKeyLCTORFDMHNKUSG-XTTLPDOESA-N |
CAS Registry1404-93-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Foot | Phase 1 | US | 21 Mar 2021 |